SHANNON JAMES SAMUEL purchased 100.0% of their position (5K shares) of XILIO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $43.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/30/2026ACC: 0001193125-26-131745
Director
Since Jun 2024
+5K
Net shares
Net buyer
$43.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$8.79
Trade value
$43.95K
% of position
100.0%
3/26/2026
5K→10K
Total
Net shares
+5K
Net value
$43.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/26/2026 | P · Purchase | +5K | $8.79 | $43.95K | 100.0% | 5K | 10K |
| Total | +5K | $43.95K | ||||||
Derivative Transactions0
No derivative transactions reported